If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Marketing Management » Marketing in Oncology
Download FREE Excerpt
6 Info Graphics
22 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Charged with overseeing global marketing and early product commercialization activities, Global Strategic Marketing (GSM) organizations in oncology face crowded markets that require high performance to be successful. The regulatory environment, regional differences and the competitive nature of the oncology marketplace make it necessary for GSM organizations to continually assess their budgets and investment strategies. This study presents spending benchmarks around key GSM activities within marketing, market intelligence and advocacy. In addition, the study presents a percentage breakdown of oncology GSM spending by phase of clinical development. Global Strategic Marketing Executives can use this study to compare their Oncology-GSM budget levels and investment allocation with industry trends.
Note: Data are presented in two segments: Large pharma companies and emerging companies.
The research employed a data gathering approach that gleaned quantitative data from a representative sample of 17 leading pharmaceutical companies with Oncology programs and portfolios.